Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Journal of Acquired Immune Deficiency Syndromes (1999)|March 9, 2017
Brief Report: Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed AdultsFrançois Raffi, Chloe Orkin, Amanda Clarke, et al.
AIDS (London, England)|August 11, 2020
HIV infection and COVID-19: risk factors for severe diseaseNicolas Etienne, Marina Karmochkine, Laurence Slama, et al.
Open Forum Infectious Diseases|January 23, 2025
Engagement in Preexposure Prophylaxis Care at 1 Year Among Men Who Have Sex With Men Enrolled in the French ANRS PREVENIR Cohort StudyGeoffroy Liegeon, Lambert Assoumou, Lydie Béniguel, et al.
AIDS (London, England)|August 3, 2023
Frailty and prefrailty phenotypes increase the odds of abnormal cognitive impairment screens in people with HIVAlain Makinson, Clotilde Allavena, Xian Abulizi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 9, 2025
Antimicrobial drug-resistant Neisseria gonorrhoeae (GC) infections in men using doxycycline postexposure prophylaxis. A substudy of the ANRS 174 DOXYVAC trialBéatrice Bercot, Lambert Assoumou, François Caméléna, et al.
The Lancet. Infectious Diseases|May 26, 2024
Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial designJean-Michel Molina, Beatrice Bercot, Lambert Assoumou, et al.
Plos One|May 22, 2013
A single HIV-1 cluster and a skewed immune homeostasis drive the early spread of HIV among resting CD4+ cell subsets within one month post-infectionCharline Bacchus, Antoine Cheret, Véronique Avettand-Fenoël, et al.
The Lancet. HIV|June 30, 2022
Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort studyJean-Michel Molina, Jade Ghosn, Lambert Assoumou, et al.
The Journal of Antimicrobial Chemotherapy|January 23, 2023
Striking differences in weight gain after cART initiation depending on early or advanced presentation: results from the ANRS CO4 FHDH cohortSophie Grabar, Valérie Potard, Lionel Piroth, et al.
The Lancet. Infectious Diseases|February 22, 2015
Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trialAntoine Chéret, Georges Nembot, Adeline Mélard, et al.
Pageof 6